Pharmacielo Ltd Market Cap ($6.80 Million)
Market Cap & Net Worth: Pharmacielo Ltd (PCLO)
Pharmacielo Ltd market cap. Pharmacielo Ltd (V:PCLO) has a market capitalization of $6.80 Million (CA$9.40 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #27864 globally and #1189 in its home market, demonstrating a -9.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmacielo Ltd's stock price CA$0.05 by its total outstanding shares 187983694 (187.98 Million). Also see Pharmacielo Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Pharmacielo Ltd Market Cap History (2018–2026)
Pharmacielo Ltd market cap history from 2018 to 2026. Data shows change from $28.56 Million to $6.80 Million (-18.53% CAGR). Check latest Pharmacielo Ltd stock price today for real-time trading data and today's change.
Pharmacielo Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmacielo Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PCLO net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.13x
Pharmacielo Ltd's market cap is 3.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $414.75 Million | $786.90K | -$34.62 Million | 527.07x | N/A |
| 2020 | $282.85 Million | $2.65 Million | -$44.26 Million | 106.58x | N/A |
| 2021 | $142.78 Million | $1.94 Million | -$26.92 Million | 73.41x | N/A |
| 2022 | $23.80 Million | $5.31 Million | -$16.04 Million | 4.48x | N/A |
| 2023 | $24.48 Million | $1.54 Million | -$16.30 Million | 15.88x | N/A |
| 2024 | $10.88 Million | $3.48 Million | -$9.14 Million | 3.13x | N/A |
Competitor Companies of PCLO by Market Capitalization
Companies near Pharmacielo Ltd in the global market cap rankings as of November 1, 2026. Also see Pharmacielo Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Pharmacielo Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Pharmacielo Ltd (2018–2026)
Market capitalization of Pharmacielo Ltd from 2018 to today. Between 2018 and today, Pharmacielo Ltd's market cap moved from $28.56 Million to $ 6.80 Million, with a yearly change of -18.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$6.80 Million | +11.11% |
| 2025 | CA$6.12 Million | -43.75% |
| 2024 | CA$10.88 Million | -55.56% |
| 2023 | CA$24.48 Million | +2.86% |
| 2022 | CA$23.80 Million | -83.33% |
| 2021 | CA$142.78 Million | -49.52% |
| 2020 | CA$282.85 Million | -31.80% |
| 2019 | CA$414.75 Million | +1352.38% |
| 2018 | CA$28.56 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Pharmacielo Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.80 Million USD |
| MoneyControl | $6.80 Million USD |
| MarketWatch | $6.80 Million USD |
| marketcap.company | $6.80 Million USD |
| Reuters | $6.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pharmacielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more